AfroCentric Investment Corporation Limited (JSE:ACT)

South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
152.00
-18.00 (-10.59%)
Mar 12, 2025, 1:39 PM SAST
-47.59%
Market Cap 1.39B
Revenue (ttm) 8.81B
Net Income (ttm) -244.25M
Shares Out 816.44M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend 0.06 (3.53%)
Ex-Dividend Date May 7, 2025
Volume 43,333
Average Volume 232,138
Open 155.00
Previous Close 170.00
Day's Range 152.00 - 155.00
52-Week Range 125.00 - 350.00
Beta 0.21
RSI 50.28
Earnings Date Mar 4, 2025

About JSE:ACT

AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers HIV and other healthcare management solutions. The company engages in the retail and wholesale of pharmaceutical products under the Activo Health, AfroCentric Technologies, AfA, Allegra, Denis, EssentialMED, Klinikka, Medscheme, Pharmacy Direct, Sc... [Read more]

Sector Healthcare
Founded 2008
Employees 5,503
Stock Exchange Johannesburg Stock Exchange
Ticker Symbol ACT
Full Company Profile

Financial Performance

In 2024, JSE:ACT's revenue was 8.90 billion, an increase of 0.60% compared to the previous year's 8.85 billion. Earnings were 55.38 million, a decrease of -69.82%.

Financial Statements

News

There is no news available yet.